Revista de la Sociedad Argentina de Diabetes (Nov 2020)

P22 Telehealth during Covid-19: patient satisfaction of virtual training on the MiniMed 670G System in people with type 1 diabetes

  • Andrea Daghero,
  • María Laura Iglesias,
  • Flavia Oliva,
  • Eugenia Piasentini,
  • Florencia Prado,
  • Paula Balossino,
  • Agustina Gesell,
  • Arly Seguel,
  • Jesica Gulmez,
  • Camila Berardo,
  • Sabina Carbajal,
  • Mariana Demarchi,
  • Melisa Echegaray,
  • Luciana García,
  • Caterina Gastin,
  • Martina Llaneza,
  • Ana Lozada,
  • Stefania Lugrin,
  • Florencia Martorell,
  • Analía Mihalik,
  • Valeria Ortiz,
  • Paula Perlo,
  • Ariela Portnoy,
  • Teresita Roman,
  • Luciana Silveira,
  • Mariela Tornese,
  • Ivana Villa

DOI
https://doi.org/10.47196/diab.v54i3Sup.406
Journal volume & issue
Vol. 54, no. 3Sup
pp. 127 – 127

Abstract

Read online

Background: the coronavirus disease (COVID-19) pandemic has challenged the ability to do face-to-face training on advanced diabetes management technologies. Like in United States and Latinamerica, in Argentina, Medtronic Diabetes shifted from occasional to 100% virtual training on all diabetes devices in mid-March 2020. Aim: to evaluate patient satisfaction of virtual training on the MiniMed™ 670 G hybrid closed-loop system in type 1 diabetes. Methods: from February to April 2020 training on the MiniMed™ 670G system was 90% completed using online platform. Virtual training satisfaction was capture through online surveys at the end of follow up (90 days). Patient satisfaction was determined by Net Promotor Score (NPS®). Continuous glucose monitoring (CGM) results were measured using the CareLink Personal database.

Keywords